Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS)
CNY 11.06
(0.36%)
CNY 11.06
(0.36%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 12.46 Billion CNY | 6.77% |
| 2022 | 11.67 Billion CNY | 1.47% |
| 2021 | 11.5 Billion CNY | 12.43% |
| 2020 | 10.23 Billion CNY | 13.48% |
| 2019 | 9.01 Billion CNY | 10.23% |
| 2018 | 8.18 Billion CNY | 18.82% |
| 2017 | 6.88 Billion CNY | 7.28% |
| 2016 | 6.41 Billion CNY | 7.89% |
| 2015 | 5.94 Billion CNY | 65.08% |
| 2014 | 3.6 Billion CNY | 10.86% |
| 2013 | 3.25 Billion CNY | 52.81% |
| 2012 | 2.12 Billion CNY | 47.76% |
| 2011 | 1.43 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 12.7 Billion CNY | -2.56% |
| 2024 Q1 | 12.88 Billion CNY | 3.32% |
| 2024 Q2 | 13.03 Billion CNY | 1.21% |
| 2023 Q3 | 11.68 Billion CNY | -4.19% |
| 2023 Q4 | 12.46 Billion CNY | 6.67% |
| 2023 FY | 12.46 Billion CNY | 6.77% |
| 2023 Q1 | 12.07 Billion CNY | 3.42% |
| 2023 Q2 | 12.19 Billion CNY | 1.01% |
| 2022 Q1 | 11.78 Billion CNY | 2.44% |
| 2022 FY | 11.67 Billion CNY | 1.47% |
| 2022 Q4 | 11.67 Billion CNY | 1.61% |
| 2022 Q3 | 11.49 Billion CNY | -2.89% |
| 2022 Q2 | 11.83 Billion CNY | 0.39% |
| 2021 FY | 11.5 Billion CNY | 12.43% |
| 2021 Q2 | 10.05 Billion CNY | -1.26% |
| 2021 Q1 | 10.18 Billion CNY | -0.45% |
| 2021 Q4 | 11.5 Billion CNY | 12.43% |
| 2021 Q3 | 10.23 Billion CNY | 1.74% |
| 2020 Q3 | 9.47 Billion CNY | 1.01% |
| 2020 Q2 | 9.37 Billion CNY | -5.75% |
| 2020 Q1 | 9.94 Billion CNY | 10.3% |
| 2020 FY | 10.23 Billion CNY | 13.48% |
| 2020 Q4 | 10.23 Billion CNY | 8.07% |
| 2019 Q3 | 8.5 Billion CNY | 3.18% |
| 2019 Q4 | 9.01 Billion CNY | 6.1% |
| 2019 FY | 9.01 Billion CNY | 10.23% |
| 2019 Q2 | 8.23 Billion CNY | -1.05% |
| 2019 Q1 | 8.32 Billion CNY | 1.76% |
| 2018 Q2 | 7.13 Billion CNY | 1.73% |
| 2018 Q3 | 7.44 Billion CNY | 4.39% |
| 2018 FY | 8.18 Billion CNY | 18.82% |
| 2018 Q4 | 8.18 Billion CNY | 9.92% |
| 2018 Q1 | 7 Billion CNY | 1.8% |
| 2017 Q2 | 5.95 Billion CNY | -5.51% |
| 2017 FY | 6.88 Billion CNY | 7.28% |
| 2017 Q4 | 6.88 Billion CNY | 8.17% |
| 2017 Q3 | 6.36 Billion CNY | 6.94% |
| 2017 Q1 | 6.29 Billion CNY | -1.86% |
| 2016 Q1 | 5.91 Billion CNY | -0.52% |
| 2016 FY | 6.41 Billion CNY | 7.89% |
| 2016 Q4 | 6.41 Billion CNY | 2.08% |
| 2016 Q3 | 6.28 Billion CNY | 5.87% |
| 2016 Q2 | 5.93 Billion CNY | 0.34% |
| 2015 Q1 | 3.47 Billion CNY | -3.54% |
| 2015 FY | 5.94 Billion CNY | 65.08% |
| 2015 Q4 | 5.94 Billion CNY | 13.59% |
| 2015 Q2 | 5.25 Billion CNY | 51.02% |
| 2015 Q3 | 5.23 Billion CNY | -0.24% |
| 2014 Q2 | 3.08 Billion CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | 3.6 Billion CNY | 0.0% |
| 2014 FY | 3.6 Billion CNY | 10.86% |
| 2013 FY | 3.25 Billion CNY | 52.81% |
| 2012 FY | 2.12 Billion CNY | 47.76% |
| 2011 FY | 1.43 Billion CNY | 0.0% |